¿Àµµ¿¬
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : Ç÷¾×, Ç÷ÀüÁöÇ÷
Á÷
ˤ
: ±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
206
ÇØ¿Ü
Yoon JS, Lee S,Sun CH, Kim D, Kim I, Yoon SS, Oh D, Yun H, Koh Y. MED-TMA: A clinical decision support tool for differential diagnosis of TMA with enhanced accuracy using an ensemble method. Thromb Res. 2020 Jun 27;193:154-159
205
ÇØ¿Ü
Yun JW, Oh J, Lee KO, Lee SJ, Kim JO, Kim NK, Kim JS, Koh Y, Yoon SS, Yhim HY, Jo SK, Park Y, Lee JE, Park J, Lee JW, Kim SH, Kim HJ, Oh D. Distinct genetic profile with recurrent population-specific mssense variants in Korean adult atypical hemolytic uremic syndrome. Thromb Res 2020 (accepted)
204
ÇØ¿Ü
Tsuda H, Noguch K, Ph D, Bereczky Z,. Lee LH, Kang D, Dusse LMS, Carvalho GMG, . Morishita E and The SSC Subcommittee on Plasma Coagulation Inhibitors of the ISTH. Racial differences in protein S Tokushima, protein C p.Arg189Trp, and protein C p.Lys193del variants as genetic risk factors for venous thromboembolism RPTH 2020 (accepted)
203
ÇØ¿Ü
Kim JW, Han SW, Cho JY, Chung IJ, Kim JG, Lee KH, Park KU, Baek SK, Oh SC, Lee MA, Oh D, Shim B, Ahn JB, Shin D, Lee JW, Kim YH. Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial. Eur J Cancer. 2020
202
±¹³»
Hong J, Lee JH, Lee JY, Lee JO, Choi WI, Ahn S, Lim YH, Bang SM, Oh D. Prominent seasonal variation in pulmonary embolism than deep vein thrombosis incidence: a Korean venous thrombosis epidemiology study. Korean J Intern Med. 2019 Oct 25. doi: 10.3904/kjim.2018.370. [Epub ahead of print]
201
ÇØ¿Ü
Kim JO, Jun HH, Kim EJ, Lee JY, Park HS, Ryu CS, Kim S, Oh D, Kim JW, Kim NK. Genetic variants of HOTAIR association with colorectal cancer susceptibility and mortality. Front Oncol 2020 Feb 7;10:72. doi: 10.3389/fonc.2020.00072. eCollection 2020
200
±¹³»
Lee H, Kang E, Kang HG, Kim YH, Kim JS, Kim HJ, Moon KC, Ban TH, Oh SW, Jo SK, Cho H, Choi BS, Hong J, Cheong HI, Oh D. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome. Korean J Intern Med. 2020 Jan;35(1):25-40
199
ÇØ¿Ü
Byun JM, Hong J, Yoon SS, Koh Y, Ock CY, Kim TM, Lee JH, Kim SH, Lee JO, Bang SM, Yhim HY, Bae SH, Mun YC, Oh D; Korean Thrombosis and Hemostasis Working Party of Korean Society of Hematology. Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy. Thromb Res. 2019 Oct 20;183:131-135
198
±¹³»
Oh J, Oh D, Lee SJ, Kim JO, Kim NK, Chong SY, Huh JY, Baker RI; Korean TTP Registry Investigators. Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura. Blood Res. 2019;54:218-228
197
ÇØ¿Ü
Ko EJ, Kim EJ, Kim JO, Sung JH, Park HS, Ryu CS, Oh J, Chong SY, Oh D, Kim NK. Analysis of the Association Between MicroRNA Biogenesis Gene Polymorphisms and Venous Thromboembolism in Koreans. Int J Mol Sci. 2019 Aug 1;20(15). pii: E3771
1
2
3
4
5
6
7
8
9
10
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729